Progestins

  • TRADE NAMES: Aygestin (Barr); Curretab; Delta-Lutin; Duralutin; Gesterol 50; Hylutin; Megace (Bristol-Myers Squibb); Micronor (Ortho); Nor-QD; Norlutate; Norlutin; Ovrette (Wyeth); Pro-Depo; Prodox; Progestaject; Provera (Pfizer)
  • INDICATIONS: Prevention of pregnancy
  • CLASS: Progestogen
  • HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Acitretin, Aprepitant, Dofetilide, Rosuvastatin, Voriconazole

Our database has 18 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
HEMATOLOGIC


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top